Eye tests could spot signs of Alzheimer’s years before symptoms first appear, new research suggests

A routine eye test could spot signs of Alzheimer’s disease years before symptoms first appear, promising research has suggested.

Experts from City St George’s, University of London say early stage cognitive decline could soon be picked up by an AI tool rolled out in opticians and ophthalmologist offices that measures changes to blood vessels in the back of the eye.

The tool, which is being tested using the health records of more than 500,000 Britons, could help dementia patients be identified and treated before the disease significantly damages their brain.

Read all about it HERE

Common Bacteria Discovered in the Eye Linked to Cognitive Decline

Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai. Published in Nature Communications, the discovery suggests this bacterium can amplify Alzheimer’s disease and points to potential interventions including inflammation-limiting therapies and early antibiotic treatment.

Read the full article HERE

Potential new treatment for Alzheimer’s disease, other neurodegenerative conditions

Investigators at Case Western Reserve UniversityUniversity Hospitals and the Louis Stokes Cleveland VA Medical Center have identified a new and promising drug to treat AD.

The drug—and their approach by identifying a new target in the brain—showed promising results in mouse models of AD. Their findings were reported in a study published May 21 in the scientific journal Proceedings of the National Academy of Sciences (PNAS).

“Our findings suggest an effective new way to safely prevent neurodegeneration and cognitive impairment in Alzheimer’s disease by directly protecting the blood-brain barrier (BBB),” said the study’s co-lead researcher Andrew Pieper, a psychiatrist and neuroscientist, the Case Western Reserve University Rebecca E. Barchas MD DLFAPA University Professor of Translational Psychiatry and the Morley-Mather Chair of Neuropsychiatry at University Hospitals Cleveland Medical Center.

Read the original article HERE

Participate in a study

Alzheimer; News from the web:

Read all about this study into Alzheimer’s and see if it is a good match for you or someone you know to participate.

Read all about it HERE

Facts and figures about Alzheimer’s for 2022

Alzheimer; News from the web:

The number of Americans living with Alzheimer’s continues to rise. Currently, an estimated 6.5 million Americans age 65 and older are living with Alzheimer’s — about 1 in 9. By 2050, the number is projected to reach nearly 13 million.

This and more facts and figures in the annual report from the Alzheimer’s association.

Read all about it HERE